A similar degree of insulin resistance and glucose intolerance was observed in both mouse models, effects which were reversed after p53 inhibition by pifithrin or Gh inhibition by pegvisomant, both treatments that reduced p53 levels in adipose tissue [76]. The gene discussed is TP53; the disease is Glucose intolerance.